Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.

Suppr

超能文献

作者信息

Ahmann D L, Bisel H F, Hahn R G

出版信息

Cancer Chemother Rep. 1974 Nov-Dec;58(6):861-5.

PMID:4615785

Abstract

摘要

相似文献

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.

Cancer Chemother Rep. 1974 Nov-Dec;58(6):861-5.

Clinical trial of isophosphamide (NSC-109724)--results and side effects.异环磷酰胺（NSC - 109724）的临床试验——结果与副作用

Cancer Chemother Rep. 1974 Nov-Dec;58(6):889-93.

A phase 2 study of intermittent high dose isophosphamide therapy of advanced colorectal cancer.

Oncology. 1974;29(1):34-9. doi: 10.1159/000224886.

Clinical pharmacology of isophosphamide.

Clin Pharmacol Ther. 1974 Jul;16(1):77-86. doi: 10.1002/cpt1974161part177.

Renal dysfunction after treatment with isophosphamide (NSC-109724).

Cancer Chemother Rep. 1974 May-Jun;58(3):375-82.

Combination chemotherapy for disseminated carcinoma of the breast.

Bol Asoc Med P R. 1975 Jun;67(6):157-63.

Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.绝经后女性转移性乳腺癌的化疗：环磷酰胺与环磷酰胺、长春新碱、甲氨蝶呤、5-氟尿嘧啶和泼尼松五药联合方案的对照试验

Prog Clin Biol Res. 1977;12:459-66.

Evaluation of single-drug versus multiple-drug chemotherapy in the treatment of advanced breast cancer.

Cancer Treat Rep. 1977 Jan-Feb;61(1):47-50.

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.

Cancer Chemother Rep. 1974 Nov-Dec;58(6):877-82.

Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide.高剂量环磷酰胺和异环磷酰胺对心脏和肺部的影响。

Cancer Res. 1974 Jul;34(7):1586-91.

引用本文的文献

Addition of drug/s to a chemotherapy regimen for metastatic breast cancer.在转移性乳腺癌化疗方案中添加药物。

Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003368. doi: 10.1002/14651858.CD003368.pub3.

Single agent versus combination chemotherapy for metastatic breast cancer.转移性乳腺癌的单药化疗与联合化疗

Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003372. doi: 10.1002/14651858.CD003372.pub3.

Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines.多西他赛-异环磷酰胺联合方案用于既往蒽环类药物治疗失败的HER2非过表达晚期乳腺癌患者。

Invest New Drugs. 2007 Oct;25(5):463-70. doi: 10.1007/s10637-007-9043-x. Epub 2007 Mar 17.

Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer.多西他赛与异环磷酰胺联合治疗蒽环类药物预处理的晚期乳腺癌患者的I-II期研究。

Br J Cancer. 2003 Apr 22;88(8):1168-74. doi: 10.1038/sj.bjc.6600887.

Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.

Cancer Chemother Pharmacol. 1982;9(2):81-4. doi: 10.1007/BF00265383.

Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.毒性及对大剂量异环磷酰胺+美司钠作为晚期乳腺癌挽救治疗的反应

J Cancer Res Clin Oncol. 1988;114(6):602-4. doi: 10.1007/BF00398184.

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector.异环磷酰胺与美司钠用于恶性疾病治疗：美司钠作为尿路保护剂。

Invest New Drugs. 1989 Jul;7(2-3):261-7. doi: 10.1007/BF00170871.

A phase II study of intensive-dose epirubicin/verapamil as induction therapy followed by intensive-dose ifosfamide for advanced breast cancer.一项关于大剂量表柔比星/维拉帕米作为诱导疗法，随后使用大剂量异环磷酰胺治疗晚期乳腺癌的II期研究。

Cancer Chemother Pharmacol. 1990;26 Suppl:S93-6. doi: 10.1007/BF00685433.

Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclines.异环磷酰胺 + 米托蒽醌用于先前接受过蒽环类药物治疗的晚期乳腺癌。

Cancer Chemother Pharmacol. 1990;26 Suppl:S81-4. doi: 10.1007/BF00685429.

Ifosfamide combination chemotherapy in advanced breast cancer.异环磷酰胺联合化疗用于晚期乳腺癌

Cancer Chemother Pharmacol. 1990;26 Suppl:S71-3. doi: 10.1007/BF00685426.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验